Serina Therapeutics, Inc. (SER) is a publicly traded Healthcare sector company. As of November 12, 2026, SER trades at $1.43 with a market cap of $38.10M and a P/E ratio of -1.04. SER moved -6.00% today. Year to date, SER is -31.54%; over the trailing twelve months it is -64.58%. Its 52-week range spans $1.14 to $7.92. Analyst consensus is buy with an average price target of $9.50. Rallies surfaces SER's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for SER combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $1.43 |
| Market Cap | $38.10M |
| P/E Ratio | -1.04 |
| EPS | $-1.91 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.92 |
| 52-Week Low | $1.14 |
| Volume | 28.22K |
| Avg Volume | 0 |
| Revenue (TTM) | $130.00K |
| Net Income | $-19.21M |
| Gross Margin | 0.00% |
2 analysts cover SER: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $9.50.